Published in Ann Rheum Dis on August 01, 1976
Neutrophil chemotaxis in rheumatoid arthritis. Effect of D-penicillamine, gold salts, and levamisole. Ann Rheum Dis (1978) 1.24
D-penicillamine and immune complex deposition. Ann Rheum Dis (1979) 1.20
Directed migration of circulating polymorphonuclear leucocytes in patients with rheumatoid arthritis: a defect in the plasma. Ann Rheum Dis (1979) 1.16
Polymorphonuclear cell function in rheumatoid arthritis and in Felty's syndrome. Ann Rheum Dis (1981) 1.15
Immune complexes in human diseases: a review. Am J Pathol (1980) 1.05
Defective polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis associated with a serum inhibitor. Ann Rheum Dis (1980) 0.97
Reactivity of low molecular weight material in cellular immune complex assays. Clin Exp Immunol (1983) 0.90
Neutrophil functions and clinical performance after total fasting in patients with rheumatoid arthritis. Ann Rheum Dis (1983) 0.84
Neutrophil chemotaxis in ankylosing spondylitis, Reiter's disease, and polymyalgia rheumatica. Ann Rheum Dis (1978) 0.80
C3 receptors on granulocytes from patients with rheumatoid arthritis and Felty's syndrome. Clin Exp Immunol (1984) 0.80
Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry (1965) 96.68
An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis. J Exp Med (1957) 5.79
Gamma globulin complexes in rheumatoid arthritis and certain other conditions. J Clin Invest (1961) 5.62
Circulating immune complexes in inflammatory bowel disease. Clin Exp Immunol (1973) 4.32
Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Clin Invest (1971) 3.61
The clearance of antigen antibody complexes from the blood by the reticuloendothelial system. J Immunol (1959) 3.25
Competition for receptors for immunoglobulin on cytotoxic lymphocytes. Clin Exp Immunol (1972) 2.77
Characterization of the gamma-globulin complexes present in certain sera having high titers of anti-gamma-globulin activity. J Clin Invest (1966) 2.06
A simplified method for the measurement of chemotaxis of polymorphonuclear leukocytes from human blood. J Lab Clin Med (1971) 1.81
The hyperviscosity syndrome in rheumatoid arthritis due to intermediate complexes formed by self-association of IgG-rheumatoid factors. Arthritis Rheum (1975) 1.54
Inhibitory effect of rheumatoid sera on cell damage by lymphocytes. Ann Rheum Dis (1972) 1.40
Hypergammaglobulinemic purpura. Studies on the unusual anti- -globulins characteristic of the sera of these patients. Medicine (Baltimore) (1971) 1.32
Lymphocyte-dependent cytotoxic antibody activity against human transplantation antigens. Transplantation (1973) 1.17
Evidence for circulating immune complexes in thyroid disease. Br Med J (1974) 1.15
In vitro cytotoxicity of human lymphocytes for sensitized chicken erythrocytes is inhibited by sera from rheumatoid arthritis patients. Scand J Immunol (1972) 1.13
IgG complexes in serum of rheumatoid arthritis patients. Scand J Immunol (1974) 0.93
Serum hyperviscosity in Sjögren's syndrome interaction between IgG and IgG rheumatoid factor. Ann Intern Med (1974) 0.87
Sjögren's syndrome: hyperviscosity and intermediate complexes. Ann Intern Med (1974) 0.86
Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol (1991) 5.38
Mechanism of antigen-driven selection in germinal centres. Nature (1990) 5.26
Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev (1972) 4.79
Circulating immune complexes in inflammatory bowel disease. Clin Exp Immunol (1973) 4.32
Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Clin Invest (1971) 3.61
An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis (1979) 3.47
Shoulder disorders in the elderly: a community survey. Arthritis Rheum (1991) 3.21
Azathioprine in rheumatoid arthritis. Br Med J (1969) 3.14
A human serum immunoglobulin with specificity for certain homologous target cells, which induces target cell damage by normal human lymphocytes. Immunology (1969) 3.12
Antigen-driven selection of virgin and memory B cells. Immunol Rev (1986) 3.10
Supervision of epileptic patients taking phenytoin. Br Med J (1970) 3.09
Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis (1981) 3.08
Effect of specific antibody to target cells on their specific and non-specific interactions with lymphocytes. Nature (1968) 2.96
Thermographic changes in keyboard operators with chronic forearm pain. BMJ (1997) 2.90
Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis. Ann Rheum Dis (1974) 2.77
Competition for receptors for immunoglobulin on cytotoxic lymphocytes. Clin Exp Immunol (1972) 2.77
Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol (1991) 2.71
Frozen shoulder: a long-term prospective study. Ann Rheum Dis (1984) 2.67
Polymyalgia rheumatica -- a clinical study with particular reference to arterial disease. J Rheumatol (1974) 2.66
Frozen shoulder: prospective clinical study with an evaluation of three treatment regimens. Ann Rheum Dis (1984) 2.60
Germinal centres in T-cell-dependent antibody responses. Immunol Today (1992) 2.47
Shoulder disorders in the elderly (a hospital study). Ann Rheum Dis (1987) 2.45
Extracorporeal shock wave therapy for lateral epicondylitis--a double blind randomised controlled trial. J Orthop Res (2002) 2.40
Extracorporeal shock wave therapy for plantar fasciitis. A double blind randomised controlled trial. J Orthop Res (2003) 2.38
The painful stiff shoulder. Rheumatol Phys Med (1972) 2.37
Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur J Immunol (1988) 2.26
Germinal centers without T cells. J Exp Med (2000) 2.25
Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J Exp Med (1996) 2.18
Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. Arthritis Rheum (1997) 2.12
Marginal zones: the major B cell compartment of rat spleens. Eur J Immunol (1981) 2.08
Cytotoxic lymphocytes from rats depleted of thymus processed cells. Nat New Biol (1971) 2.02
The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. II. The mechanism of target cell damage by lymphoid cells from immunized rats. Immunology (1970) 1.96
Lymphocyte proliferation to artery antigen as a positive diagnostic test in polymyalgia rheumatica. Ann Rheum Dis (1975) 1.94
T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med (1998) 1.91
Distinct short-lived and long-lived antibody-producing cell populations. Eur J Immunol (1986) 1.89
A prospective double blind dummy placebo controlled study comparing triamcinolone hexacetonide injection with oral diclofenac 50 mg TDS in patients with rotator cuff tendinitis. J Rheumatol (1990) 1.87
Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med (2000) 1.87
Wound healing after operations of patients with rheumatoid arthritis. J Bone Joint Surg Br (1973) 1.86
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatology (Oxford) (2003) 1.83
Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol (1991) 1.82
A simplified method for the measurement of chemotaxis of polymorphonuclear leukocytes from human blood. J Lab Clin Med (1971) 1.81
Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis (1989) 1.81
Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol (1983) 1.80
Neutrophil trafficking into inflamed joints in patients with rheumatoid arthritis, and the effects of methylprednisolone. Arthritis Rheum (1996) 1.77
Variability in cytokine and cell adhesion molecule staining in arthroscopic synovial biopsies: quantification using color video image analysis. J Rheumatol (1997) 1.77
Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J Biol Chem (1990) 1.77
Tennis elbow--a reappraisal. Br J Rheumatol (1989) 1.76
Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol (1997) 1.76
CD23: a multi-functional receptor/lymphokine? Immunol Today (1989) 1.76
Light chain isotype-associated suppression of normal plasma cell numbers in patients with multiple myeloma: Medical Research Council's Working Party for Leukaemia in Adults and the Oxford Lymphoma Group. Int J Cancer (1979) 1.75
Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis (1989) 1.74
Rotator cuff degeneration and lateral epicondylitis: a comparative histological study. Ann Rheum Dis (1994) 1.73
The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J (1983) 1.72
Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet (1992) 1.72
Extracorporeal shock-wave therapy for tendonitis of the rotator cuff. A double-blind, randomised, controlled trial. J Bone Joint Surg Br (2002) 1.71
Migrant mu+ delta+ and static mu+ delta- B lymphocyte subsets. Eur J Immunol (1982) 1.71
The long-term outcome of rotator cuff tendinitis--a review study. Br J Rheumatol (1988) 1.69
Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone? Ann Rheum Dis (1988) 1.69
Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia. Arthritis Rheum (2001) 1.67
Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Ann Rheum Dis (1989) 1.66
Joint fluid cytology in Reiter's disease. Ann Rheum Dis (1978) 1.65
Failure of certain cytotoxic lymphocytes to respond mitotically to phytohaemagglutinin. Nature (1970) 1.62
The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum (1993) 1.62
Diagnosis and relation to general health of shoulder disorders presenting to primary care. Rheumatology (Oxford) (2005) 1.61
A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J Exp Med (1995) 1.60
The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. I. Clinical effects. J Rheumatol (1988) 1.60
Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports. Thorax (1992) 1.59
Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis (1994) 1.58
Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis (1980) 1.57
Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production. J Exp Med (1997) 1.57
Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study. Ann Rheum Dis (1987) 1.54
A comparison of follow-up regimes in rheumatoid arthritis. Ann Rheum Dis (1980) 1.53
Nature of anaemia in rheumatoid arthritis. 8. Iron content of synovial tissue in patients with rheumatoid arthritis and in normal individuals. Ann Rheum Dis (1968) 1.51
Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia. Br Med J (1973) 1.50
Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool. J Exp Med (1997) 1.46
The effect of peripheral lymphocytes from patients with inflammatory joint disease on human target cells in vitro. Clin Exp Immunol (1968) 1.46
Lateral humeral epicondylitis--a study of natural history and the effect of conservative therapy. Br J Rheumatol (1983) 1.46
Is therapeutic ultrasound effective in treating soft tissue lesions? Br Med J (Clin Res Ed) (1985) 1.46
The natural history of low grade non-Hodgkin's lymphoma and the impact of a no initial treatment policy on survival. Q J Med (1991) 1.45
Dendritic cells associated with plasmablast survival. Eur J Immunol (1999) 1.44
Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure (1995) 1.44
Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis (1994) 1.43
Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis (1986) 1.42
Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders. Clin Exp Immunol (1973) 1.41
Inhibitory effect of rheumatoid sera on cell damage by lymphocytes. Ann Rheum Dis (1972) 1.40
Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine. Clin Exp Immunol (1974) 1.39
T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur J Immunol (1999) 1.39
Immunological studies in frozen shoulder. J Rheumatol (1983) 1.38
Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes. Eur J Immunol (2001) 1.38
Case of Reiter's disease treated with lincomycin hydrochloride. Br Med J (1967) 1.37
Effector activating determinants on IgG. II. Differentiation of the combining sites for C1q from those for cytotoxic K cells and neutrophils by plasmin digestion of rabbits IgG. Immunology (1974) 1.36
Cells of the marginal zone of the spleen are lymphocytes derived from recirculating precursors. Eur J Immunol (1981) 1.36
Corticosteroid prescribing in rheumatoid arthritis--the fiction and the fact. Br J Rheumatol (1985) 1.35
The IgG subclass responses of human lymphocytes to B-cell activators. Immunology (1983) 1.35
Pulse methylprednisolone therapy in rheumatoid arthritis: unproved therapy, unjustified therapy, or effective adjunctive treatment? Ann Rheum Dis (1990) 1.33